Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gualberto Ruano

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Personalized Medicine|May 26, 2018
Quo vadis personalized medicine?Gualberto Ruano
Personalized Medicine|May 26, 2018
Genomas, IncGualberto Ruano, Robert Scherrer
Connecticut Medicine|June 14, 2006
The pharmacogenomics of warfarin (Coumadin) administrationGualberto Ruano, Bruce Bower
Pain Physician|December 5, 2018
Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 PolymorphismsGualberto Ruano, Jonathan A Kost
Hospitals & Health Networks|January 8, 2008
DNA-guided decision supportBruce Bower, Joseph Klimek, Neil Yeston, et al.
Pain Physician|March 24, 2022
Automated Extraction of Pain Symptoms: A Natural Language Approach using Electronic Health RecordsAmisha D Dave, Gualberto Ruano, Jonathan Kost, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|December 31, 2014
Ethnic variation in weight loss, but not co-morbidity remission, after laparoscopic gastric banding and Roux-en-Y gastric bypassJanet Ng, Richard Seip, Andrea Stone, et al.
Human Brain Mapping|December 12, 2007
Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICAJingyu Liu, Godfrey Pearlson, Andreas Windemuth, et al.
Clinical Pharmacology and Therapeutics|September 24, 2019
PharmVar GeneFocus: CYP2D6Charity Nofziger, Amy J Turner, Katrin Sangkuhl, et al.
Clinical Pharmacology and Therapeutics|January 2, 2021
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid TherapyKristine R Crews, Andrew A Monte, Rachel Huddart, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Personalized Medicine|May 26, 2018
Quo vadis personalized medicine?Gualberto Ruano
Personalized Medicine|May 26, 2018
Genomas, IncGualberto Ruano, Robert Scherrer
Connecticut Medicine|June 14, 2006
The pharmacogenomics of warfarin (Coumadin) administrationGualberto Ruano, Bruce Bower
Pain Physician|December 5, 2018
Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 PolymorphismsGualberto Ruano, Jonathan A Kost
Hospitals & Health Networks|January 8, 2008
DNA-guided decision supportBruce Bower, Joseph Klimek, Neil Yeston, et al.
Pain Physician|March 24, 2022
Automated Extraction of Pain Symptoms: A Natural Language Approach using Electronic Health RecordsAmisha D Dave, Gualberto Ruano, Jonathan Kost, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|December 31, 2014
Ethnic variation in weight loss, but not co-morbidity remission, after laparoscopic gastric banding and Roux-en-Y gastric bypassJanet Ng, Richard Seip, Andrea Stone, et al.
Human Brain Mapping|December 12, 2007
Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICAJingyu Liu, Godfrey Pearlson, Andreas Windemuth, et al.
Clinical Pharmacology and Therapeutics|September 24, 2019
PharmVar GeneFocus: CYP2D6Charity Nofziger, Amy J Turner, Katrin Sangkuhl, et al.
Clinical Pharmacology and Therapeutics|January 2, 2021
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid TherapyKristine R Crews, Andrew A Monte, Rachel Huddart, et al.
Pageof 1